With arguments imminent in the U.S. Supreme Court's latest Second Amendment clash, the U.S. Department of Justice is suddenly taking comparable cases to the justices, suggesting that a ruling for accused domestic abusers might also benefit "armed drug users" and unleash "serious problems" in the judiciary.
After methodically amassing U.S. Supreme Court victories against agency enforcers and regulators, a legal crusade against "administrative state" powers is poised to parlay piecemeal wins into a climactic conquest during the high court's new term, which is already teeming with anti-agency cases.
The U.S. Supreme Court's endorsement of False Claims Act exposure for purportedly inadvertent compliance blunders is forcing more companies to settle or roll the dice at trials, which rarely occur in the FCA realm because of fearsome financial risks, according to attorneys and early interpretations of the high court's holding.
The Biden administration's unveiling of drugs in the inaugural round of Medicare price negotiations will add fresh fuel to a litigation firestorm engulfing the program, helping challengers contend they face imminent risks of getting burned financially and possibly sparking new or expanded suits, experts say.
A piqued panel of Eleventh Circuit judges chastised counsel Tuesday amid revelations they issued a lengthy opinion on controversial legal strategies involving the Americans with Disabilities Act, debated rehearing the case and entertained supplemental briefs all after the litigation had become moot without their knowledge.